Clinical Trials Browser

Phase NA × Recruiting × Adenocarcinoma of Lung × Clear all

Adenocarcinoma of Lung

NCT07479095 2026-03-20

KETO-FDG Lung

Phase NA Recruiting

30 enrolled

Thoracic

Adenocarcinoma of Lung

NCT07219251 2026-03-03

EVLC

Phase NA Recruiting

194 enrolled

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Small Cell Lung Carcinoma

NCT07423169 2026-02-20

Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer

Phase NA Recruiting

10 enrolled

Thoracic

Adenocarcinoma of Lung

NCT03199651 2026-02-19

BLCIO

Phase NA Recruiting

3,584 enrolled

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT07161713 2025-09-23

RESET

Phase NA Recruiting

100 enrolled

GastrointestinalThoracic

Adenocarcinoma of Lung, Colonic Neoplasms, Disease, Lung Neoplasms

NCT06796816 2025-01-28

BIVA-18

Phase NA Recruiting

1,000 enrolled

Thoracic

Adenocarcinoma of Lung, Lung Neoplasms, Sarcopenia

NCT06056115 2023-09-28

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

Phase NA Recruiting

20 enrolled

Thoracic

Adenocarcinoma of Lung

Clinical Trials

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

KETO-FDG Lung

EVLC

Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer

BLCIO

RESET

BIVA-18

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic